AI assistant
USCOM LIMITED — Capital/Financing Update 2012
Aug 19, 2012
65979_rns_2012-08-19_80476f46-60ad-405c-9677-ca2b4ec9b417.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Uscom Limited
ABN 35 091 028 090 Suite 1, Level 7, 10 Loftus Street Sydney NSW 2000 Australia T +612 9247 4144 F +612 9247 8157 www.uscom.com.au
M A R K E T A N N O U N C E M E N T
Uscom opens private placement fully subscribed
Monday 20th of August 2012: Uscom (ASX code: UCM).
Uscom Ltd today announced that it will issue 5.8 million shares at 12 cents as part of a private placement to sophisticated investors. Subscriptions have been received for all 5.8m of the current placement, however additional applications will be received and any additional shares issued subject to shareholder approval at the AGM on November 6[th] 2012.
The 5.8 million shares represent the balance of the Companies 15% capacity under listing rule 7.1. The Board expects to issue the shares on Friday 24[th] of August.
Uscom Ltd currently has 54,124,488 fully paid ordinary shares on issue prior to this private placement.
About Uscom
Uscom Limited is an Australian medical device company which listed on the Australian Stock Exchange in December 2003. Uscom has developed a Non Invasive Cardiac Output Monitor. The USCOM is a simple, cost-effective and non-invasive device that measures heart function, detects irregularities and guides treatment. The USCOM device has major applications in Paediatrics, Emergency and Intensive Care Medicine and Anesthesia, and is a tool of choice for management of adult and paediatric sepsis, and for the guidance of fluid therapy.
USCOM has global regulatory approval and the device is currently marketed in North America, South America, Europe, the Middle East, Australia & New Zealand, China and SE Asia.
Uscom Contacts Rob Phillips Executive Chairman [email protected]
Tom Rowe Company Secretary [email protected]